. Prolonged case of pneumonia in which vaccine was repeatedly given. The first two doses had not much effect, but after his own strain of pneumococci was added to the stock vaccine, the patient apparently reacted better, but despite the fall in the temperature, he developed an empyema and meningitis which post-mortem were found to be due to pneumococci.
Case XIII.?A man, aged 48 years, was admitted on the third day of his illness. The lung showed rather indefinite physical signs, and there was no true consolidation. On the following (fourth) day he was given an injection of 3,500,000 stock vaccine, which was followed by a lytic fall of temperature extending over the fifth and sixth days (Fig. 1, p. 23) .
Case XIV.?A man, aged 39 years, admitted with basal pneumonia of the left lung on the eighth day of his attack, was given a small dose of 2,000,000 cocci on the same afternoon, and had his crisis that night.
Case XV.?A boy, aged 5f years, was admitted on the third day of his illness with pneumonia of the left base. On the fifth and seventh days he received injections of 2,000,000 cocci without the course of the disease being affected, the temperature remaining high and the consolidation spreading.
A third injection of 200,000 cocci on the evening of the eighth day was followed by a slight drop in the temperature, which culminated in the crisis twenty-four hours afterwards. This boy had had a previous attack of pneumonia five months before (Fig. 2, p injection of 2,000,000 stock vaccine on the sixth day, which was followed by a pseudocrisis within the next twelve hours. The temperature then rose again for a few hours before definitely coming down on the eighth day (Fig. 1, p. 23 ).
This series of 19 cases is too small to enable me to come to any definite conclusion regarding the value of vaccine treatment.
It included patients of all ages, the youngest of the series being 2J years and the oldest 74 years. The vaccine was tried at all stages of the disease, and in varying doses.
The effect of the vaccine treatment was certainly not miraculous. Four patients (Cases II, IV, VIII, XI) died of the disease, while a fifth (Case XVII), after coming through the acute stage, succumbed to exhaustion on the sixth day after the crisis. This mortality is not very satisfactory, but it compares not unfavourably with that of the series of 10 cases, with 2 deaths, which was treated in the same wards without vaccine during the same period.
Of the fatal cases in the vaccine series, the only instance in which the vaccine seemed to do harm was in Case II, in which death from hyperpyrexia occurred within eighteen hours of the administration of the vaccine. In Case IV the first two injections of the stock vaccine had no apparent effect, but the third and fourth injections, which contained an autogenous strain, were followed by such marked improvement that the patient seemed to be on the high road to recovery.
A fifth injection was followed by an alarming increase in the severity of the symptoms; first empyema and, later, meningitis developed. In Case VIII no improvement followed two injections, each of 23,000,000 cocci, on the sixth and eighth days of the disease. The consolidation continued to spread, and the patient succumbed on the tenth day. In the remaining fatal case (XI) the injection of a small dose of 3,500,000 pneumococci on the seventh day of the disease produced a temporary improvement for thirty-six hours, but the patient succumbed to the disease fifty-three hours after the vaccine was given. 18,000,000. 18,000,000. 3,500,000.
1,000,000 repeated on 5th, 6th, and 7th days.
1,000,000.
18,000,000 on 3rd day, and 2,000,000 on 5th day 10,000,000. In four cases in which the excretion of chloride in the urine was estimated the vaccine seemed to produce no effect. The proportion of chlorides to a unit quantity of urine remained the same, and any increased excretion of chlorides was due to an increase in the total flow of urine. 2. The mortality in the vaccine series (21 per cent) was slightly higher than in the control series (20 per cent).
3. The early administration of vaccine did not abort the disease, nor prevent complications.
4. Complications were relatively frequent in the vaccine series, viz., one instance of meningitis, two of empyema, and one of hyperpyrexia.
